Breaking News

Schott Developing U.S. Syringe Production

Schott's Pharmaceutical Packaging business plans to expand both its product line and production capacity in the U.S.

Schott‘s Pharmaceutical Packaging business plans to expand both its product line and production capacity in the U.S., adding the full line of Schott ready-to-fill syringe products to its portfolio of vials and cartridges manufactured at its existing Pharmaceutical Packaging facility in Lebanon, PA.

The company expects to add 125 new jobs to its Lebanon facility and will begin hiring this year. The expansion into the syringe market represents a $46 million investment in the facility.

The expansions are intended to meet the accelerating demand for syringes in the North American market. Market analysis shows global demand for prefilled syringes will grow at a rate of 8-10% annually for the next several years.

“Demand for syringes in the U.S. has grown steadily in recent years and will continue with the increased incidence and detection of chronic diseases,” said Gary Waller, director North American Sales & Marketing for Schott Pharmaceutical Packaging.”Schott is well positioned to leverage its high-quality global production capabilities for the U.S. market.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters